Erratum for Lawton et al., J Clin Oncol 23 (4) 800-807.

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                            What's this?

ERRATUM

In the Abstract, the first sentence of the Results section read:

With a median follow-up of 6.5 years for all patients and 9.5 years for living patients, estimated progression-free survival with prostate-specific antigen (PSA) level less than 1.5 ng/mL at 5 and 9 years was 54% and 10%, respectively, for patients who received immediate LHRH agonist versus 33% and 4% for patients who received radiation alone with hormonal manipulation instituted at time of relapse (P < .0001).

Whereas it should have read:

With a median follow-up of 6.5 years for all patients and 9.5 years for living patients, estimated progression-free survival with prostate-specific antigen (PSA) level less than 1.5 ng/mL at 5 and 9 years was 54% and 33%, respectively, for patients who received immediate LHRH agonist versus 10% and 4% for patients who received radiation alone with hormonal manipulation instituted at time of relapse (P < .0001).

In the Results section of the article, the second sentence in the fourth paragraph read:

At 5 and 9 years, biochemical control by PSA less than 1.5 ng/mL was 54% and 10%, respectively, for arm I, and 33% and 4% for arm II.

Whereas it should have read:

At 5 and 9 years, biochemical control by PSA less than 1.5 ng/mL was 54% and 33%, respectively, for arm I, and 10% and 4% for arm II.

In the Results section of the article, the last sentence of the sixth paragraph read:

Five- and 9-year absolute survival rates were 72% and 62%, respectively, for all patients in arm I, and 50% and 38%, respectively, for all patients in arm II (P = .23).

Whereas it should have read:

Five- and 9-year absolute survival rates were 72% and 50%, respectively, for all patients in arm I, and 62% and 38%, respectively, for all patients in arm II (P = .23).

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                            What's this?